SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-23-029188 from BIO KEY INTERNATIONAL INC (BKYI)

BIO KEY INTERNATIONAL INC
Date: Oct. 27, 2023 · CIK: 0001019034 · Accession: 0001437749-23-029188

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-275003

Date
October 27, 2023
Author
Title: Co-President
Form
CORRESP
Company
BIO KEY INTERNATIONAL INC

Letter

Re: BIO-key International, Inc.

bkyi20231027c_corresp.htm

October 27, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-1004

Registration Statement on Form S-1, as amended

File No. 333-275003

Ladies and Gentlemen:

As the placement agent of the proposed offering of BIO-key International, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 a.m., Eastern Time, on Monday, October 30, 2023, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through October 27, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 26, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
Maxim Group LLC

Show Raw Text
CORRESP
1
filename1.htm

	bkyi20231027c_corresp.htm

October 27, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-1004

			Re:
			BIO-key International, Inc.

			Registration Statement on Form S-1, as amended

			File No. 333-275003

Ladies and Gentlemen:

As the placement agent of the proposed offering of BIO-key International, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:00 a.m., Eastern Time, on Monday, October 30, 2023, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through October 27, 2023, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red” copies of the Preliminary Prospectus dated October 26, 2023, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

			Very truly yours,

			Maxim Group LLC

			By:

			/s/ Clifford A. Teller

			Name: Clifford A. Teller

			Title: Co-President